Home-based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery
Effect of Home-based Preoperative Exercise Training on Quality of Life After Lung Cancer Surgery: A Randomized Controlled Trial
1 other identifier
interventional
46
1 country
1
Brief Summary
Lung cancer accounts for over 11% of global cancer incidence and is the leading cause of cancer death, with numbers in 2020 reaching 1.8 million deaths worldwide. For early-stage lung cancer patients, surgical resection is the recommended treatment and the intervention associated with a better prognosis. However, in consequence of surgery there is a substantial deterioration in health-related quality of life across most dimensions, especially in the first month, with 100% of lung cancer patients concerned about the limitations in their physical function and 96% about the levels of fatigue and pain after lobectomy. Additionally, some patients developed postoperative pulmonary complications, which are associated with increased length of hospital stay and higher risk of mortality. In this context, and considering that the number of lung cancer cases with an indication for surgery will increase by 60% from 2018 to 2040, to find feasible and effective interventions that could optimize postoperative recovery is of major clinical relevance. The primary purpose of this study will be to evaluate the efficacy of home-based preoperative exercise training to improve health-related quality of life after lung cancer surgery. The secondary purpose of this study will be to evaluate the efficacy of the home-based exercise program to improve physical performance and to reduce postoperative complications /length of hospital stay. Participants will be randomly allocated to a preoperative exercise intervention, that will consist of combined aerobic and resistance exercise, or to a control group that will receive usual care (i.e., no exercise training). Based on the strong evidence indicating a therapeutic effect of exercise training on fatigue and physical function, domains of HRQOL especially affected after lung cancer surgery, the investigators hypothesized that the home-based exercise program will be effective to improve these domains before surgery and attenuate its deterioration after surgery, optimizing the recovery in postoperative HRQOL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2022
CompletedFirst Posted
Study publicly available on registry
July 21, 2022
CompletedStudy Start
First participant enrolled
September 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2023
CompletedJune 28, 2023
June 1, 2023
10 months
July 13, 2022
June 27, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in health-related quality of life
Will be assessed through the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire C30 (QLQ-C30) (version 3.0). The QLQ-C30 is composed of 30 questions, including five multi-item functioning scales, three multi-item symptom scales, six single-item symptom scales, and a two-item global health status scale \[GHS\]. Scores range from 0 to 100 points, with a higher score on the functioning scales indicating a higher level of functioning, whereas a higher score on the symptom scales indicates a higher level of symptom burden. In addition, the investigators will assess EORTC QLQ-C30 summary score (SumSc) because it provides a psychometrically more robust alternative to the GHS score that is frequently used as the primary HRQOL endpoint in clinical trials. The SumSc is calculated from the mean of 13 of the 15 QLQ-C30 scores (the GHS and financial impact scales are excluded).
Baseline to 2-3 days before surgery
Changes in health-related quality of life
Will be assessed through the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire C30 (QLQ-C30) (version 3.0). The QLQ-C30 is composed of 30 questions, including five multi-item functioning scales, three multi-item symptom scales, six single-item symptom scales, and a two-item global health status scale \[GHS\]. Scores range from 0 to 100 points, with a higher score on the functioning scales indicating a higher level of functioning, whereas a higher score on the symptom scales indicates a higher level of symptom burden. In addition, the investigators will assess EORTC QLQ-C30 summary score (SumSc) because it provides a psychometrically more robust alternative to the GHS score that is frequently used as the primary HRQOL endpoint in clinical trials. The SumSc is calculated from the mean of 13 of the 15 QLQ-C30 scores (the GHS and financial impact scales are excluded).
Baseline to 3-5 weeks after surgery
Secondary Outcomes (11)
Changes in exercise capacity
Baseline to 2-3 days before surgery
Changes in exercise capacity
Baseline to 3-5 weeks after surgery
Changes in handgrip strength
Baseline to 2-3 days before surgery
Changes in handgrip strength
Baseline to 3-5 weeks after surgery
Changes in five times sit to stand test
Baseline to 2-3 days before surgery
- +6 more secondary outcomes
Study Arms (2)
Preoperative home-based exercise training
EXPERIMENTALPatients allocated to this group will receive usual care plus a preoperative home-based exercise program consisting of aerobic and resistance exercise. In addition, a physical therapist will carry out weekly telephone supervision with all participants.
Control Group
NO INTERVENTIONPatients allocated to this group will receive usual care and must complete the outcome measures. In addition, a physical therapist will carry out weekly telephone calls with all participants to monitor adverse events.
Interventions
Home-based aerobic and resistance exercise training (preoperative period) Dose of aerobic exercise: 1. Type: Walking 2. Frequency: 3 sessions per week 3. Duration: 30 minutes 4. Intensity: Rate of perceived exertion on Borg Category Ratio-10 (3-5) 5. Progression: Increase the walking duration in 10 minutes (after week 2) Dose of resistance exercise: 1. Type: Six exercises for upper and lower limbs using bodyweight and free-wights of 1-2kg 2. Frequency: 2 sessions per week 3. Duration: 2 sets x 15 repetitions 4. Rest in-between sets: 45 seconds 5. Intensity: Rate of perceived exertion on Borg Category Ratio-10 (3-5) 6. Progression: Increase the number of sets (3 sets of 15 repetitions after week 2) Weekly telephone supervision: A physical therapist will carry out weekly telephone calls with all participants to monitor adverse events and recommend strategies to overcome barriers that arise during the exercise program.
Eligibility Criteria
You may qualify if:
- Scheduled for surgical treatment of suspected or confirmed lung cancer (clinical stage IIIA or less)
- Waiting time for surgery of at least two weeks from baseline assessment
- Medical clearance to exercise.
- Signed informed consent prior to initiation of study-related procedures
You may not qualify if:
- Metastatic cancer
- Presence of physical or mental disabilities that contraindicated exercise training or physical testing
- Unable to communicate in Portuguese or English
- Performing combined aerobic plus resistance training over the past month (self-reported ≥2 days a week, ≥30 minutes each session).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Portuguese Oncology Institute of Coimbra
Coimbra, 3000-075 Coimbra, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pedro FA Machado
Center for Innovative Care and Health Technology, Polytechnic of Leiria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 13, 2022
First Posted
July 21, 2022
Study Start
September 2, 2022
Primary Completion
June 26, 2023
Study Completion
June 26, 2023
Last Updated
June 28, 2023
Record last verified: 2023-06